Replies to post #89246 on Amarantus Bioscience Holdings Inc (AMBS)

[JPetroInc]

with shares - like everything else - of course

April 17th, 2013

http://seekingalpha.com/article/1347691-amarantus-lympro-could-be-a-game-changer-for-alzheimers-diagnosis

"Amarantus paid Memory Dx 2.0 million shares of common stock, and will pay a royalty equal to 9% of the net proceeds of all sales resulting from the license. Amarantus will fund the validation study for LymPro, and as has agreed to pay $50,000 to prepare the laboratory for the necessary CLIA work, which we expect to begin in the 3rd quarter of 2013. Memory Dx LLC is entitled to a $1.0 million milestone payment (in cash or stock) upon the successful completion of the phase II validation study, facilitating commercial sale of the product as an "aid to the diagnosis of Alzheimer's disease."

_________________________________________________________________________________________________________

you proclaim to be the single most biggest AMBS shareholder, and yet you don't know this fact ???

Whew..........